Evidence Hub

The Burden of Hepatitis E among Patients with Hematological Malignancies: a Retrospective European Cohort Study

J. von Felden, L. Alric, S. Pischke, C. Aitken, S. Schlabe, U. Spengler, M. T. Giordani, P. Schnitzler et al.

Journal of Hepatology, 2019

50 participants · 88 citations

Abstract

BACKGROUND

The burden of hepatitis E virus (HEV) infection has been scarcely reported among patients with haematological malignancy.

METHODS

We conducted a retrospective, multi-centre cohort study across 11 European centres and collected clinical characteristics of 50 patients with haematological malignancy and RNA-positive, clinically overt hepatitis E between April 2014 and March 2017. Primary endpoint was HEV-associated mortality; secondary endpoint was HEV-associated liver-related morbidity.

RESULTS

The most frequent underlying haematological malignancies were aggressive non-Hodgkin lymphoma (NHL) (34%), indolent NHL (iNHL) (24%), and acute leukaemia (36%). Twenty-one (42%) patients had received allogeneic haematopoietic stem cell transplantation (alloHSCT). Death with ongoing hepatitis E occurred in eight (16%) patients, including one with iNHL and one >100 days after alloHSCT in complete remission, and was associated with male sex (p=0.040), cirrhosis (p=0.006) and alloHSCT (p=0.056). Blood-borne transmission of hepatitis E was demonstrated in five (10%) patients, and associated with liver-related mortality in two patients. Hepatitis E progressed to chronic hepatitis in 17 (34%) patients overall, and in ten (47.6%) and six (50%) alloHSCT and iNHL patients, respectively. Hepatitis E was associated with acute or acute-on-chronic liver failure in four (8%) patients with 75% mortality. Ribavirin was administered to 24 (48%) patients and HEV clearance rate was 79.2%.…

How strong is the evidence?

Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 50 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free